SKAN.SW
Get informed when a big investor buys or sells
+ FollowOvervalued by 54.1% based on the discounted cash flow analysis.
| Market cap | $1.59 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.22 (0.31%) |
| Earnings per Share | $0.72 |
| Beta | 0.75 |
| Outstanding Shares | 22,479,642 |
| P/E Ratio | 53.16 |
|---|---|
| PEG | -34.51 |
| Price to Sales | 2.42 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. Th...